FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

4011311000001103: Solarcaine 0.5% gel (Schering-Plough Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17741901000001115 Solarcaine 0.5% gel (Schering-Plough Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17742001000001111 Solarcaine 0.5% gel (Schering-Plough Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Solarcaine 0.5% gel (Schering-Plough Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) Is a Product containing precisely lidocaine hydrochloride 5 milligram/1 gram conventional release cutaneous gel true Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) Has excipient Tartrazine stain false Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) Has active ingredient Lidocaine hydrochloride false Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) Has active ingredient Lidocaine false Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) Has specific active ingredient Lidocaine hydrochloride true Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Solarcaine 0.5% gel (Schering-Plough Ltd) 135 gram Is pack of False Solarcaine 0.5% gel (Schering-Plough Ltd) Inferred relationship Existential restriction modifier
Solarcaine 0.5% gel (Schering-Plough Ltd) 135 gram Has AMP True Solarcaine 0.5% gel (Schering-Plough Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start